- Home
- SGN vs PTPI Comparison
SGN vs PTPI Comparison
Compare SGN & PTPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGN
- PTPI
- Stock Information
- Founded
- SGN 2019
- PTPI 2020
- Country
- SGN United States
- PTPI United States
- Employees
- SGN N/A
- PTPI N/A
- Industry
- SGN
- PTPI Biotechnology: Pharmaceutical Preparations
- Sector
- SGN
- PTPI Health Care
- Exchange
- SGN Nasdaq
- PTPI Nasdaq
- Market Cap
- SGN 4.1M
- PTPI 3.6M
- IPO Year
- SGN 2023
- PTPI N/A
- Fundamental
- Price
- SGN $3.20
- PTPI $0.36
- Analyst Decision
- SGN
- PTPI
- Analyst Count
- SGN 0
- PTPI 0
- Target Price
- SGN N/A
- PTPI N/A
- AVG Volume (30 Days)
- SGN 81.7K
- PTPI 1.7M
- Earning Date
- SGN 12-24-2024
- PTPI 11-13-2024
- Dividend Yield
- SGN N/A
- PTPI N/A
- EPS Growth
- SGN N/A
- PTPI N/A
- EPS
- SGN N/A
- PTPI N/A
- Revenue
- SGN $576,488.00
- PTPI $4,022,389.00
- Revenue This Year
- SGN N/A
- PTPI N/A
- Revenue Next Year
- SGN N/A
- PTPI $0.76
- P/E Ratio
- SGN N/A
- PTPI N/A
- Revenue Growth
- SGN 147.76
- PTPI N/A
- 52 Week Low
- SGN $2.80
- PTPI $0.22
- 52 Week High
- SGN $73.44
- PTPI $2.27
- Technical
- Relative Strength Index (RSI)
- SGN 32.03
- PTPI 48.85
- Support Level
- SGN $2.80
- PTPI $0.26
- Resistance Level
- SGN $3.59
- PTPI $0.59
- Average True Range (ATR)
- SGN 0.82
- PTPI 0.06
- MACD
- SGN -0.07
- PTPI 0.01
- Stochastic Oscillator
- SGN 8.79
- PTPI 16.38
About SGN Signing Day Sports Inc.
Signing Day Sports Inc is a technology company developing and operating platforms aiming to allow significantly more student-athletes to go to college and continue playing sports. Its platform Signing Day Sports is a digital ecosystem to help athletes get discovered and recruited by coaches and recruiters across the country. It currently fully supports football and baseball, and it plans to expand the Signing Day Sports platform to include additional sports.
About PTPI Petros Pharmaceuticals Inc.
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. It focuses on therapeutics that promote medication adherence, tolerability, and preservation of male organic function. The company's operating segment includes Prescription Medications and Medical Devices. It generates maximum revenue from the Medical Devices segment. The Prescription Medications segment consists of operations related to vacuum erection devices, which are sold domestically and internationally.